Defining Durations of Use for Certain Medically Important Antimicrobial Drugs for Food-Producing Animals

  17 February 2026

This guidance targets sponsors of approved NADAs and ANADAs for medically important antimicrobial drugs used in the medicated feed of food-producing animals that currently have one or more indications without a defined duration of use. It outlines a voluntary framework to update these products so that all such antimicrobials are used in accordance with principles of judicious use, including establishing clearly defined treatment durations. The objective is to reduce the risk of antimicrobial resistance by aligning animal use of medically important drugs with public health protection efforts, and it provides specific recommendations for sponsors on how to revise approved conditions of use to support this goal.

Further reading: US FDA
Author(s): Center for Veterinary Medicine
Healthy Animals  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!